Cytokine receptors have dierent signaling requirements which ultimately lead to various physiological responses. In an eort to precisely characterize the molecular determinants involved in the proliferative response mediated by cytokines, we examine dose-dependent proliferation of the bc (GM-CSF, IL-3, IL-5) and homodimeric (G-CSF, TPO) cytokine receptors. Here we report that all cytokine receptors tested activate mostly STAT3 and STAT5. While STAT3 had a positive eect on bc cytokine receptor dependent proliferation, STAT5 was strongly inhibitory. Similarly, G-CSF and TPO lead to activation of STAT3 and STAT5 but, unlike the bc cytokine receptors, both stimulated cellular growth. On the other hand, Ras activation was necessary for all receptor mediated proliferation with the exception of G-CSF R. Truncated mutants of the receptors intracellular domains were used to delineate the functional domains involved in JAK/ STAT and Ras activation linked to cellular growth. For instance, we revealed a critical role for the speci®c alpha subunit of the bc receptors in triggering receptor activation, STAT3 stimulation and proliferation, while Ras activation originates from the distal intracellular portion of the bc subunit. Finally, we showed that proximal STAT activation is the triggering event of G-CSF and TPO receptor function.
Introduction
The bc subfamily of cytokine receptors (GM-CSF, IL-3, IL-5) has been reported to rely upon the common bc subunit to transmit signals and mediate physiological responses. So far, the function of the speci®c a-chain has been largely restricted to binding its cognate ligand. Upon binding, several cytoplasmic proteins are activated: members of the JAK/STAT family, tyrosine kinases including Lyn, Yes, Fyn, Fes, Hck, and Ras/MAPK kinases (Blalock et al., 1999) . Studies focusing on identifying the domains responsible for the various signaling functions have revealed that the bc proximal cytoplasmic region is conserved among many cytokine receptors. This so-called`box 1' domain is essential to JAK2 activation but not sucient for its binding. The distal cytoplasmic region is characterized by the presence of a number of tyrosine phosphorylation sites which contribute to the activation of Shc and SHP2. The ability of Shc and SHP2 to interact with the adapter complex Grb2-Sos thus provides a mechanistic link to Ras activation (Bon®ni et al., 1996; Downward, 1996) . While the respective contributions of the intracellular domains to signaling are becoming more evident, their role in driving various physiological response still remains controversial. For instance, deletion of the bc proximal cytoplasmic domain (amino acids 456 ± 517) results in loss of proliferation (Muto et al., 1995; Quelle et al., 1994) , while other ®ndings suggest a role for this same region in promoting dierentiation and/or survival (Adachi et al., 1999a,b) , functions seemingly opposite to proliferation. Likewise, overlapping domains in the carboxy terminus of the bc chain display dierent functions. For example, a region of bc distal to amino acids 558 is essential to GM-CSF induced dierentiation (Smith et al., 1997) , while expression of a truncated mutant at position 544 leads BA/F3 hematopoietic cells to undergo apoptosis (Kinoshita et al., 1995) .
The role of the speci®c alpha subunits in both signaling and cellular functions has been recently brought under scrutiny but still remains largely obscure. It is well accepted though that the integrity of the a chain is required for optimal function. Deletion studies of the cytoplasmic region of GM-CSF Ra indicate that this domain is absolutely required in GM-CSF functionality (Matsuguchi et al., 1997; Weiss et al., 1993) , and thus impairs the proliferative response to GM-CSF (Lia et al., 1996) . Also, a mutant of IL-5 Ra lacking its cytoplasmic domain does not respond to IL-5 stimulation (Takaki et al., 1993) . Likewise, lack of the intracellular IL-3 Ra region results in loss of proliferation and signaling (Barry et al., 1997) . These divergent activities (proliferation, dierentiation, cell survival) speci®c to the a subunits have all been shown to depend upon activation of JAK/STAT (Barry et al., 1997; Doyle and Gasson, 1998) . They also clearly illustrate the current lack of understanding to de®ne convincing structure ± function relationships for the a subunits.
Unlike other cytokine receptors, members of the single-chain family (G-CSF, TPO, EPO, GH, PRL, OB) do not rely upon a common subunit to initiate signal transduction. Instead, ligand binding has been shown to induce homodimerization of the receptor which is sucient to mediate physiological responses. Roles for the intracellular domains of homodimeric receptors in mediating cytokine function have been proposed. For instance, mutations studies of the proximal cytoplasmic region have established a link between proliferation and JAK/STAT activation (Gurney et al., 1995; Witthuhn et al., 1993) . However, a TPO receptor mutant deleted of the proximal ten amino acids lacks the ability to activate the JAK/STAT pathway but still retains its proliferative properties (Dorsch et al., 1997) . Most likely, its cell growth eects are mediated through Shc and/or MAPK activation (Dorsch et al., 1997) . Analyses of the TPO receptor distal domain indicate that TPO proliferation is impaired by C-terminal truncation of the last 53 amino acids. Surprisingly, this domain also confers dierentiation and viability properties (Drachman and Kaushansky, 1997; Porteu et al., 1996) . Various proteins such as Shc, SHIP, PI-3 kinase and MAPK have been reported to interact with this domain (Drachman and Kaushansky, 1997; Gurney et al., 1995; Morita et al., 1996; Rouyez et al., 1997) . In the G-CSF receptor, JAK2 activation lies within the proximal domain and also drives proliferation, while STAT activation is mediated through tyrosine residues located in the distal portion of the receptor (Barge et al., 1996; Chakraborty et al., 1999; Nicholson et al., 1995) . However, tyrosine residue 764 is crucial in maintaining proliferation and dierentiation of a myeloid cell line (de Koning et al., 1998) . The Cterminus region of the G-CSF receptor is also involved in the activation of various proteins such as Src tyrosine kinases and MAPK, whose activation correlates with both proliferation or dierentiation outcomes (de Koning et al., 1998; Ward et al., 1998) .
We sought to determine the signaling requirements of various classes of cytokine receptors, and their importance in contributing to cellular proliferation. Two dierent classes of receptors were considered: (i) the bc family of heterodimeric cytokine receptors which shares a common bc subunit; and (ii) cytokine receptors which exist as functional homodimers such as G-CSF and TPO.
Results

Ras signaling in cytokine-dependent cell proliferation
To understand the signaling requirements of various families of cytokine receptors in the context of cellular proliferation using our proprietary platform technology R-SAT TM , we ®rst characterized the NIH3T3 ®bro-blastic cell line used. In absence of exogeneously expressed cytokine receptors, and upon ligand exposure, no response for any of the cytokine tested was observed ( Figure 1a ). Moreover, in these conditions no endogeneous bc (GM-CSF Ra, IL-3 Ra, IL-5 Ra) or homodimeric (G-CSF R, TPO R) cytokine receptors protein could be detected (Figure 1b ). These data indicate that endogeneous receptors, if any, do not interfere with ectopic expression of cytokine receptors. Only when cells were transfected with the cytokine receptors could a ligand-dependent response be observed. For each cytokine receptor tested, the optimum response could be maintained within a fourfold dierence in the amount of receptor transfected (Figures 1a,1b) . These results suggest that comparative analyses of cytokine receptor mediated signaling pathways using this cell system can be done with reliable con®dence, since even signi®cant dierences in protein expression (up to fourfold) would aect the receptor response only marginally. We then investigated the eects of Ras/MAPK activation in modulating cytokine dependent cell proliferation. Expression of either the Grb2-Sos1 complex, or c-Ha-Ras alone, was used as a means to stimulate the Ras pathway. The Grb2-Sos1 system has been shown to be an ecient way of activating Ras and its downstream components (Downward, 1996) . Receptor and Selection Ampli®cation Technology (R-SAT TM ) assay was used to assess the eects of Ras activation on proliferation. R-SAT TM is a functional cell-based assay which allows monitoring of receptormediated cell proliferation in a ligand dependent manner (Brauner-Osborne and Brann, 1996 ; see Materials and methods), and that can be used to dissect signaling pathways (Burstein et al., 1997) . NIH3T3 ®broblasts were transiently transfected with individual receptors in absence or presence of the Ras promoting expression vectors along with a b-galactosidase reporter gene. b-galactosidase being under the control of a constitutive promoter is thus expressed as a function of proliferation. Activation of the Ras pathway via the Grb2 ± Sos1 complex lead to a signi®cative enhancement in cell proliferation mediated by the bc cytokine receptors GM-CSF, IL-3 and IL-5 (Figure 2a ). This response was ligand-dependent as, in absence of ligand, no basal activity in either inactive or active Ras pathway conditions were observed (data not shown). This also indicates that endogeneous cytokine receptors, if any, did not interfere with the responses seen. Large dierences between the two homodimeric cytokine receptors were apparent: while G-CSF proliferation was not aected by Ras activation, TPO mediated cellular growth was considerably stimulated in presence of Ras (by a factor of 4 ± 5-fold). Protein levels of the transfected Grb2 and Sos1 were similar in all conditions tested as assayed by Western blotting (Figure 2b) , ruling out the possibility that the dierences in receptor responses were the result of dierent expression levels in Grb2 and Sos1.
To con®rm the proliferative role of Ras activation on all cytokine receptors but G-CSF R, the eect of a Ras dominant negative construct (Ras N17) was investigated (Mattingly et al., 1994) . EC50s observed in R-SAT TM for GM-CSF (20 ± 50 pM), IL-3 (20 ± 50 pM) and IL-5 (1 ± 10 pM) were comparable to previously described physiological EC50 values from functional assays data ( Figure 3a) . Likewise, EC50 values of G-CSF (15 ± 50 pM) and TPO (100 ± 300 pM) were also similar to previously reported data ( Figure  3b ). Increasing amounts of the Ras dominant negative construct Ras N17 eciently inhibited proliferation mediated by GM-CSF, IL-3 and IL-5 ( Figure 3a ). This considerable inhibition (475%) was seen even at low doses of Ras N17, suggesting a strong dependence of bc cytokine receptor upon the Ras pathway to drive cell proliferation. Con®rming the above results, G-CSF mediated proliferation was only partially aected by Ras inhibition (with a 50 ± 60% inhibition at the highest dose of Ras N17), while TPO mediated cellular growth was highly sensitive to and fully inhibited by Ras inactivation ( Figure 3B ). Thus, Ras activation plays a prominent role in proliferation mediated by most of the cytokine receptors GM-CSF, IL-3, IL-5 and TPO. However, Ras does not signi®cantly contribute to G-CSF dependent growth.
STAT specificity in cytokine signaling
Cytokine receptor function relies partially on activation of JAK/STAT pathway (Darnell, 1997; Silvennoinen et al., 1997; Wilks and Oates, 1996) . To determine the respective importance of STAT proteins in cytokine signaling in our system, we examined their ability to promote transcription of a STAT responsive reporter gene. A construct containing three repeats of the consensus STAT binding element GAS (5'-TTCCCGGAA-3') upstream of the luciferase reporter gene (36GAS-Luc) was generated. This construct responded eciently to all STAT proteins with similar eciency (data not shown). Reporter gene assays indicate that upon ligand binding both GM-CSF and Figure 3 Eects of Ras dominant negative RasN17. Dose dependent proliferation of bc (a) or G-CSF and TPO (b) cytokine receptors was evaluated using R-SAT TM in transiently transfected cells with increasing amounts of RasN17. For each receptor, the fold response was normalized to the curve generated with the receptor only (the responses of each receptor were: GM-CSF R 4.8-fold, IL-3 R 6.3-fold, IL-5 R 8.9-fold, G-CSF R 4.6-fold and TPO R 5.7-fold). Three independent experiments were done in duplicates with similar results. Results (mean+s.t.d.) are an example of a representative experiment IL-3 receptor activation lead to a 10-fold increase in STAT dependent transcription (Figure 4 ). This liganddependent increase in GAS-luciferase activity in GM-CSF R and IL-3 R expressing cells and seen with the G-CSF and TPO receptors as well (see below), re¯ects the functional response of the receptor itself as no increase in luciferase activity was evident in absence of receptor (data not shown), and supports that the receptors eciently transduce signals by recruiting endogenous STAT dependent pathways. Co-transfection with STAT1 partially inhibited GM-CSF activation (by about 30%) but not that of IL-3. However, both STAT3 and STAT5 considerably augmented GM-CSF and IL-3 dependent activation. STAT2 and STAT6 did not signi®cantly aect either receptors. Similar results were found with the IL-5 receptor, especially with regards to the STAT3 and STAT5 potentiation of cytokine activation (data not shown).
G-CSF activation was strongly enhanced by STAT3 and STAT5, in a manner reminiscent of the bc cytokine receptors (Figure 4 ). STAT1, 2 and 6 did not signi®cantly aect this response. On the other hand, STAT3 and STAT5 considerably potentiated TPO activation while STAT1 partially suppressed it. Expression levels of the dierent STATs were comparable (data not shown), indicating that the eects seen do not originate because of varying amounts of proteins expressed. Thus, STAT signaling by the bc cytokine receptors GM-CSF, IL-3, IL-5 and the homodimeric receptors G-CSF and TPO is essentially relying upon STAT3 and STAT5. On the other hand, STAT1 acts most likely as an inhibitory factor (Levy and Gilliland, 2000) .
In an eort to correlate STAT signaling and proliferation, we used R-SAT TM to assess the eects of the various STAT proteins in in¯uencing cytokinedependent cell growth. STAT3 was found to strongly potentiate proliferation by GM-CSF, IL-3 and IL-5 receptors ( Figure 5 ). STAT5, however, signi®cantly reduced the proliferative eects of these same receptors. None of the other STATs had any signi®cant eects even though all were expressed at similar levels ( Figure 5 ). In this experiment, no endogeneous STAT proteins could be detected mostly because the levels of Figure 4 Contribution of STAT3 and STAT 5 to cytokine receptor activation. Cells were transiently transfected with each cytokine receptor expression vector in absence or presence of the STAT constructs. Luciferase activity was determined from transcriptional activation of the 36GAS-Luc construct, a luciferase reporter gene construct containing three copies of the consensus STAT response element. After transfection, cells were incubated with their respective ligands for 48 h. Errors represent mean+s.t.d. of three independent experiments done in duplicate. Statistical analyses were performed using ANOVA non parametric test (** P50.05, *** P50.01) transfected STATs were comparatively more important. However, we and others have shown that all STATs are expressed at detectable levels in NIH3T3 ®broblasts (data not shown; Haque et al., 1998; Patel et al., 1996) . In contrast, G-CSF dependent proliferation was increased by both STAT3 and STAT5 ( Figure  5 ). Also, a signi®cant inhibition by both STAT1 and STAT2 was detected. On the other hand, TPO receptor proliferation was increased in presence of STAT1 and STAT6 (a 2 ± 2.5-fold increase), but the most striking TM provided the means to assess proliferative eects. Responses were normalized to the response observed with the receptors only. Errors represent mean+s.t.d. of three independent experiments done in duplicate. Statistical analyses were performed using ANOVA non-parametric test (* P50.1, ** P50.05, *** P50.01). Protein expression levels of the dierent STATs are indicated eects were seen both with STAT3 and STAT5 (4-and 6-fold increase, respectively). A set of STAT dominant negative constructs were used to con®rm the distinctive roles of STAT3 and STAT5. These mutants, STAT3 D680 and STAT5 D689 lack the C-terminus portion of the protein downstream of the SH2 domain and act as dominant negative entities (Figure 6c) . In presence of the STAT3 D680 construct, proliferation by GM-CSF, IL-3 and IL-5 were eciently inhibited (Figure 6a) . Overexpression of STAT5 D689 resulted in marginal improvements of proliferation. In contrast, G-CSF and TPO dependent proliferation were strongly inhibited by elevated expression of both STAT3 and STAT5 dominant negative mutants (Figure 6b ). Similar results were obtained for all ®ve receptors by using a dierent set of STAT dominant negative mutants (STAT3 Y705F and STAT5 Y694F) in which a critical phosphorylation residue has been inactivated (data not shown).
Our results thus indicate that bc cytokine receptor signaling is largely dependent upon STAT3 and 5 activation, and that their respective proliferative eects can be physically dissociated. For instance, in our system, STAT3 promotes proliferation while STAT5 inhibits cell growth. Likewise, G-CSF and TPO receptors signaling requires STAT3 and STAT5 activation. However, both STATs lead to enhanced proliferation.
Intracellular domains of cytokine receptors mediating proliferation
A possible explanation for the observed dierences in signaling and proliferation between the two groups of cytokine receptors could be related to the beta chain that is common to the bc receptors. We therefore undertook to clarify the roles of the dierent cytokine receptors subunits. Cytokine receptors deletion mutants in which intracellular domains have been partially or fully removed were generated. The distal truncation mutants GM-CSF Ra D374, bc D444 and bc D576 strongly inhibited GM-CSF mediated cell growth to an extent of 60 ± 70% (Figure 7a) . Similarly, expression of the GM-CSF Ra D346 mutant almost completely inhibited proliferation. Thus, proliferation driven by GM-CSF is highly dependent on the integrity of both a and bc intracellular domains, but is still partially sustainable when the intracellular domain of the bc subunit is lacking. In absence of the cytoplasmic domain of GM-CSF Ra, however, no cell growth was possible. When both GM-CSF receptor subunits were partially deleted of their intracellular portions, no growth was observed either (data not shown). IL-3 proliferation was dierently aected by deletions of the cytoplasmic domains of the a and bc subunits. Removal of the distal portion of the IL-3 receptor alpha (IL-3 Ra D352) lead to a 60% decrease in cellular growth. Distal deletion of the bc subunit (bc D576), as well as proximal deletion of either subunits, lead to a almost complete loss of growth (Figure 7a ). This suggests that IL-3 growth- (16, 56, 206 relative to the wild-type construct). Luciferase activity was determined from transcriptional activation of the 36GAS-Luc construct, a luciferase reporter gene construct containing three copies of the consensus STAT response element. Errors represent mean+s.t.d. of two independent experiments done in triplicate mediating signaling primarily originates from the distal portion of the bc receptor, even though an important contribution is made by the IL-3 Ra subunit. More striking, IL-5 mediated proliferation appeared strictly dependent upon the presence of intact subunits, as even partial deletion of either a or bc subunits lead to a complete loss of cell growth (Figure 7a) .
The eects of similar deletions on G-CSF and TPO proliferation were also investigated. Distal cytoplasmic deletion mutants G-CSF R D702 and TPO R D557 retained about 25 ± 30% of their proliferative capacities (Figure 7b ), indicating that growth signaling for these receptors relies primarily upon the distal intracellular part of the molecules. Proximal deletions completely abolished cellular proliferation for both receptors (data not shown).
Proliferation and Ras/STAT signaling domains of cytokine receptors
We then attempted to determine the signaling properties of the intracellular domains of the cytokine receptors, especially through STAT (3 and 5) and Ras pathways. R-SAT TM proliferation responses for each receptor mutant were evaluated for their sensitivity to STAT and Ras dominant negative constucts. Complete deletion of the cytoplasmic portion of GM-CSF Ra (D346) showed that the remaining proliferative response was strictly Ras dependent ( Figure 8a ). Diminished proliferative responses of GMCSF R bc D576 and bc D444 were Ras sensitive, indicating thas Ras-dependent proliferation however is initiated from the distal cytoplasmic portion of the common bc subunit (Figure 8a ). In contrast, the response observed in absence of the intracellular portion of bc (D444) was fully inhibited by expression of a STAT D680 mutant, but not by Ras N17. Partial and complete deletion of the GM-CSF Ra subunit (D374 and D346, respectively) indicates that the STAT binding region is located in the distal intracellular region of the GM-CSF receptor alpha (downstream of residue 576). On the other hand, IL-3 mediated proliferation was dependent upon the binding of STAT3 to the distal portion of the IL-3 Ra subunit as shown in Figure 7b . Similar to GM-CSF signaling, IL-3 dependent Ras proliferation was mediated via interaction with the distal cytoplasmic region of the bc cytokine receptor.
In contrast, the proximal cytoplasmic domain of the G-CSF receptor was found to mediate STAT-dependent proliferation (STAT3 and 5) (Figure 8c) . Deletion of the distal portion of the TPO receptor (D557) was not aected by expression of the STAT dominant negative constructs, nor by Ras N17, suggesting that the proximal intracellular portion of the TPO receptor leads to proliferation through activation of both Ras and STAT pathways.
Different outcomes in FDCP-1 myeloid cell line upon STAT5 activation by G-CSF or IL-3 treatment
To understand whether the dierential eect of STAT5 induction on cellular commitment upon activation of bc or single-chain cytokine receptors is a general phenomenon, we investigated the myeloid cell line FDCP-1. Cells were treated for a week either with G-CSF or IL-3. A small but signi®cant increase in STAT5 expression level could be observed after 7 days for both G-CSF and IL-3 treatment compared to control (Figure 9a ). In contrast, no dierences in STAT3 protein levels could be detected after 7 days. Cells were then examined for morphological evidence of myeloid dierentiation. Interestingly, the number of cells in the G-CSF treated samples was signi®cantly lower than in the IL-3 treated samples (data not shown). Upon G-CSF treatment, most cells had dierentiated into granulocytes by day 7 (Figure 9b) as assessed by morphology (Ilaria et al., 1999) . In contrast, the phenotype of the IL-3 treated cells were similar to that of undierentiated FDCP-1 myeloid cells. Finally to con®rm their granulocytic phenotype, G-CSF treated cells were analysed for the expression of the granulocytic/monocytic dierentiation marker CD11b. A signi®cant increase in the protein levels of CD11b could be detected in G-CSF treated cells when compared to controls (Figure 9b ). However, IL-3 treated cells did not show any increase in CD11b expression levels. Thus, in FDCP-1 cells, G-CSF treatment leads to a sustained STAT5 activation which, in turns, initiates and drives a granulocytic dierentiation program. In contrast, IL-3 treatment, while also leading to STAT5 activation, does not translate into dierentiation but rather in proliferation. Therefore the ligand-dependent dual activity of STAT5, established using R-SAT TM in the ectopic cell line NIH3T3, appears to be a general phenomenon that has physiological implications. Hence, this dual activity of STAT5 appears to be dependent upon the nature of the cytokine as well as the cellular type. 
Discussion
Our results shed new light on the respective contributions of the STAT and Ras signaling pathways in cytokine mediated proliferation. Receptor and Selection Ampli®cation Technology (R-SAT TM ), a powerful functional assay to monitor cellular proliferation in a ligand-dependent manner, was used to perform those studies.
We demonstrated that, upon activation, cytokine receptors sharing the common bc subunit, i.e. receptors for GM-CSF, IL-3 and IL-5, activate both STAT and Ras pathways. Activation of both pathways is crucial to initiate and sustain proliferation since inhibition of either ones lead to a considerable impairment in cellular growth. The TPO cytokine receptor was found to respond similarly, activating both STAT and Ras signaling. However, proliferation mediated by another homodimeric cytokine receptor G-CSF R appeared to be strongly dependent upon activation of the STAT pathway, and did not particularly rely on Ras. These ®ndings, which agree with previously reported data (Darnell, 1997; Ihle, 1996; Watanabe and Arai, 1996; Wilks and Oates, 1996) , illustrate the critical importance of STAT signaling pathway in cytokine proliferation, and also reveals that proliferation mediated by most cytokine receptors, but not all, requires Ras signaling.
Our analysis of the STAT proteins involved in cytokine dependent activation revealed that STAT3 and STAT5 are the only STAT family members strongly activated upon ligand binding in all receptors tested. STAT1, upon GM-CSF and TPO receptor activation only, lead to a signi®cant inhibition of STAT dependent transcription. However, while both STAT3 and STAT5 were activated, their eects on proliferation varied greatly depending upon the cytokine receptor. For instance, growth mediated by the bc cytokine receptors was potentiated by STAT3 but inhibited by STAT5. In contrast, both STAT3 and STAT5 promoted proliferation of G-CSF and TPO receptors. Thus, STAT3 acts as a generic proliferation promoting agent. STAT3 has been shown to stimulate the growth of a variety of cell lines and to be an active component in a number of oncogenic pathways (Bromberg et al., 1998; Turkson et al., 1999) . Furthermore, naturally occuring oncogenic variants of STAT3 have been isolated (Bromberg et al., 1999) . On the other hand, STAT5 has a more dual nature. In our R-SAT TM system, it negatively aects proliferation from bc cytokine receptors but stimulates growth from G-CSF and TPO receptors. In the FDCP-1 myeloid cell line, depending upon the cytokine, STAT5 activation can lead to proliferation or dierentiation (Bourette et al., 1995; Ilara et al., 1999) . Most likely, its dual function is mediated through the common bc subunit itself. We found that deletion of the complete cytoplasmic domain of the bc subunit (bc D444), when compared to a more distal deletion (bc D576) hardly aected cytokine proliferation (Figure 7a ). Thus it is likely that the proximal domain of the bc subunit mediates STAT5 activation and thereby its dual eects. In a physiological context, STAT 5 activation could then potentially lead cells towards dierentiation and/ or promote survival/proliferation. In support, a viability domain in this region has been previously described (Inhorn et al., 1995) , promoting cell survival as well as dierentiation (Blalock et al., 1999) . Furthermore, our study of the myeloid cell line FDCP-1 indicates that treatment with dierent cytokines, both of which lead to STAT5 activation, translates into dierent cellular outcomes. For instance, IL-3 stimulates FDCP-1 proliferation (Bourette et al., 1995) while G-CSF induces monocytic dierentiation (Ilara et al., 1999) (Figure 9 ). Thus, STAT5 dualistic nature is context dependent, de®ned by the cellular type and the cytokine.
The contribution of Ras signaling in cytokine dependent proliferation is crucial for all cytokine receptors tested with the exception of the G-CSF receptor. In the bc cytokine receptors, we mapped out Ras activation to the distal cytoplasmic part of the bc subunit (Barge et al., 1996) . Consequently, deletion of this domain considerably impaired GM-CSF, IL-3 and IL-5 proliferative functions (Figure 8a ). While Ras activation is a step in G-CSF signaling (Rausch and Marshall, 1999) , our results indicate that proliferation is mostly dependent upon activation of the JAK/STAT pathway. Indeed, G-CSF receptor proliferative function, contrary to other cytokine receptors, was only partially impaired when the dominant negative mutant Ras N17 was expressed. In the TPO receptor, Ras activation correlated with the proximal cytoplasmic domain (upstream of amino acid 557).
Deletion of the distal cytoplasmic domain of the bc subunit (bc D576) aects cytokine proliferation in very dierent ways. GM-CSF, when compared to IL-3 and IL-5, was the least aected with a still considerable loss of cell growth function (down by 60 ± 70 %). In these mutants, proliferation was not aected by a Ras dominant negative mutant. These results indicate that the distal portion of the bc receptor mediates Ras activation and thus demonstrate a crucial function of this pathway in cytokine proliferation (Barge et al., 1996; Blalock et al., 1999) . Also, an important contribution to cell growth is provided by the speci®c alpha subunits. Removal of the intracellular domain of the alpha subunit of GM-CSF R (GM-CSF Ra D346) leads to a complete loss of proliferation. Similar results were observed with the IL-3 and IL-5 receptor alpha subunits. Previous reports suggested that the integrity of the cytoplasmic domain of the alpha subunit might be required for receptor activation (Barry et al., 1997; Kouro et al., 1996; Ronco et al., 1994) . Our results con®rm these ®ndings and further demonstrate that the alpha subunits are critical not only in triggering receptor activation, but in establishing proper physiological responses such as proliferation. Most likely, the contribution of the alpha subunits in proliferation lie in their ability to transduce unique mitogenic signals, rather than harboring a support function for the bc subunit. Hence, mutants carrying partial deletions of the alpha subunit (GM-CSF Ra D374, IL-3 Ra D352, IL-5a D389) have weak proliferative eects and are impaired in their STAT3 activation.
Analyses of the homodimeric G-CSF and TPO receptors revealed that truncation mutants of the distal cytoplasmic region (G-CSF D702 and TPO R D557) are considerably impaired in their proliferative abilities. Interestingly, neither Ras (for the TPO R) nor JAK/ STAT pathways were aected in these mutants. Instead, we mapped out STAT activation within the proximal intracellular portion of the G-CSF receptor (Nicholson et al., 1995) . Similarly, this same region of the TPO receptor was found to mediate JAK/STAT as well as Ras activation. Various proteins such as Lyn (Kasper et al., 1999) , Hck (Ward et al., 1998) , Syk (Kasper et al., 1999) , Shc (de Koning et al., 1998 ), Grb2 (de Koning et al., 1996 , JNK and ERK kinases (Rausch and Marshall, 1997) have been reported to interact with the C-terminus of the G-CSF receptor and mediate physiological responses. A dierent set of polypeptides interacts with the carboxyl portion of the TPO receptor: Shc (Gurney et al., 1995) , SHIP (Drachman and Kaushansky, 1997), PI-3 kinase (Morita et al., 1996) and MAP kinases (Rouyez et al., 1997) . Our dominant negative mutants studies demonstrate the importance of JAK/STAT and Ras signaling in cytokine proliferation, but also suggest that signaling originating from the proximal cytoplasmic region synergize with transducing pathways activated from the distal portion of receptors. Alternatively, it is possible that signaling originates from the proximal intracellular domains and is then ampli®ed via the distal region. In support of this hypothesis, using transgenic mice lacking the C-terminal 60 amino acids of the TPO receptor, it has been recently shown that an important function of the distal region of the receptor is to potentiate signaling information emanating from the proximal cytoplasmic domain (Luoh et al., 2000) . Likewise, the proximal domain of G-CSF R have been shown to rely upon the integrity of the distal region to mediate JAK/STAT activation and proliferation (Barge et al., 1996) . This potentiation role of the distal cytoplasmic domain could thus be a general feature of homodimeric cytokine receptors since a similar mechanism has also been hypothesized for the EPO receptor (Yoshimura and Misawa, 1998) .
In conclusion, we have demonstrated a critical role for STAT3 and STAT5 in cytokine signaling, as well as an important contribution of Ras. While STAT3 behaves as a generic promoting proliferation agent, STAT5 has a dualistic role on cellular destiny that is dependent upon the nature of the cytokine. Moreover, our work provides novel insight in the receptor domains and functions associated with proliferation.
Materials and methods
Plasmids
Human IL-3 and IL-5 receptor alpha subunits were isolated by PCR from cDNAs using the following primers: (IL-3 Ra) 5'-GCACACGGGAAGATATCCAGGAAAC-3' and 5'-GG-CGCTTCGGACGAAATTACAC-3', (IL-5 Ra) 5'-CATTTC-TCAGGCCAGGCACATTG-3' and 5'-AGTCTGAGGTGA-GTCAAGCAGGC-3'. Primers for isolating the human TPO receptor were: 5'-CCTGAAGGGAGGATGGGCTAA-3' and 5'-GGTGAGGTCTGGGGTGCTTGTG-3'. Human STAT1, STAT2, STAT3 and STAT5 were isolated by PCR from cDNAs reverse-transcribed from mRNAs tissues (Clontech). All PCR products were initially cloned into PCR2.1 TOPO (Invitrogen) and then subcloned into mammalian expression vectors. Truncation mutants were generated by using the PCR site directed mutagenesis protocol from Quick Change (Stratagene). STAT3 D680 and STAT5 D689 deletion mutants were generated using the same strategy, speci®cally by inserting a TGA (Stop codon) downstream of residues 680 and 689, respectively. The 36GAS-Luc STAT responsive Luciferase construct was generated by inserting the following sequence at the Sac I/Nhe I site of the pGL2-promoter vector (Promega): 5'-TGGTAAGAGCTCTTCCCGGAATTCCCG-GAATTCCCGGAAGCTAGCCTT-3'. All constructs were then sequence con®rmed. The b-galactosidase reporter gene was described (Burstein et al., 1995) .
Ligands
Human recombinant GM-CSF, IL-3 and IL-5 were purchased from Peprotech. Stock solutions at 7.14 10 76 M, 10 76 M and 10 76 M respectively were made in PBS containing 0.1% bovine serum albumin (BSA). Human recombinant TPO and G-CSF were also from Peprotech. 2.7 10 77 M and 5.0 10 77 M stock solutions were made in PBS 0.1% BSA.
R-SAT TM assays
R-SAT TM (Receptor and Selection Ampli®cation Technology) is a proprietary cell-based functional assay that allows one to monitor receptor-dependent proliferative responses. Its principles reside in the genetic selection and the ampli®cation of the cytokine receptors in a ligand-dependent manner. This process is achieved by partial cellular transformation through the overcome of contact inhibition and the loss of growth factor dependency. Monitoring is achieved by transfecting the cells with a b-galactosidase reporter gene vector whose expression is under a constitutively active promoter. Brie¯y, NIH3T3 ®broblasts were plated overnight in 96-wells plates in DMEM 10% calf serum (Gibco BRL) and grown to 60 ± 70% con¯uency prior to transfection. Transient transfections were performed using Superfect or Polyfect (Qiagen) according to the manufacturer's instructions. Typically a transfection mix would consist of the receptor and the b-galactosidase expression vectors, in absence or presence of various signaling molecules (STAT, Ras_). Sixteen hours post-transfection, cells were incubated with dierent doses of ligand in DMEM containing 2% Cyto-SF3 (Kemp Technologies) to generate a dose response curve. After 5 days, plates were developed by adding onto the washed cells a solution containing the b-galactosidase substrate o-nitrophenyl-dgalacto pyranoside ONPG (in phosphate-buered saline with 5% Nonidet P-40 detergent) as described (Burstein et al., 1995) . Plates were read using a microplate reader at 405 nm. Data from R-SAT TM assays were ®t to the equation: r=A+B(x/(x+c)), where A=minimum response, B=maximum response minus minimum response, c=EC50, r=response, and x=concentration of ligand. Curves were generated using the curve ®tting softwares Excel Fit and GraphPad Prism (San Diego, CA, USA).
